$2.81 0.05 (+1.63%)
2/13/2012 9:45 AM

Corcept Therapeutics, Inc. (NASDAQ:CORT)

CAPS Rating: 2 out of 5

A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.

Featured Broker Partners


Advertisement